Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Iridex (IRIX) Liabilities and Shareholders Equity (2016 - 2025)

Iridex (IRIX) has 15 years of Liabilities and Shareholders Equity data on record, last reported at $28.4 million in Q3 2025.

  • For Q3 2025, Liabilities and Shareholders Equity fell 5.97% year-over-year to $28.4 million; the TTM value through Sep 2025 reached $123.3 million, down 5.1%, while the annual FY2024 figure was $29.1 million, 15.39% down from the prior year.
  • Liabilities and Shareholders Equity reached $28.4 million in Q3 2025 per IRIX's latest filing, down from $31.6 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $50.5 million in Q4 2021 and bottomed at $28.0 million in Q1 2021.
  • Average Liabilities and Shareholders Equity over 5 years is $38.7 million, with a median of $35.9 million recorded in 2023.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 77.6% in 2021, then fell 22.26% in 2023.
  • A 5-year view of Liabilities and Shareholders Equity shows it stood at $50.5 million in 2021, then fell by 16.33% to $42.3 million in 2022, then dropped by 18.57% to $34.4 million in 2023, then decreased by 15.39% to $29.1 million in 2024, then fell by 2.68% to $28.4 million in 2025.
  • Per Business Quant database, its latest 3 readings for Liabilities and Shareholders Equity were $28.4 million in Q3 2025, $31.6 million in Q2 2025, and $34.2 million in Q1 2025.